What is the appropriate empiric intraperitoneal (IP) antibiotic regimen, including dosing, for peritonitis in a patient with a peritoneal dialysis (PD) catheter, and how should therapy be adjusted for a β‑lactam allergy?

Empiric Intraperitoneal Antibiotics for PD-Associated Peritonitis

For empiric treatment of peritoneal dialysis-associated peritonitis, administer intraperitoneal vancomycin (loading dose 20 mg/kg, then 500 mg in each exchange) PLUS an antipseudomonal agent—either ceftazidime (125 mg/L per exchange) or an aminoglycoside like gentamicin (0.6 mg/kg per exchange)—given continuously in all exchanges. 1

Standard Empiric Regimen

The empiric regimen must cover both Gram-positive organisms (including MRSA) and Gram-negative organisms (including Pseudomonas):

Vancomycin Dosing (IP):

• Loading dose: 20 mg/kg (up to 2 grams) in one exchange
• Maintenance: 500 mg in each exchange (continuous dosing) OR 15-20 mg/kg every 5-7 days (intermittent dosing)
• Recent pharmacokinetic data suggests the continuous regimen with 50 mg/L per exchange may optimize intraperitoneal exposure 2

PLUS Gram-Negative Coverage (choose one):

Option 1 - Ceftazidime (IP):

• Loading dose: 500 mg per exchange
• Maintenance: 125 mg/L in each exchange (continuous)
• Preferred over aminoglycosides to avoid ototoxicity and nephrotoxicity 3

Option 2 - Gentamicin (IP):

• Loading dose: 0.6 mg/kg per exchange
• Maintenance: 0.6 mg/kg in one exchange daily
• Monitor levels if available; avoid prolonged use due to toxicity risk

Option 3 - Cefepime (IP):

• 125 mg/L per exchange (continuous)
• Broader spectrum alternative to ceftazidime

β-Lactam Allergy Adjustments

For patients with documented severe β-lactam allergy (anaphylaxis, Stevens-Johnson syndrome):

Replace the cephalosporin/β-lactam with:

• Aminoglycoside-based regimen: Vancomycin PLUS gentamicin (as dosed above) 4
• Fluoroquinolone alternative: Ciprofloxacin 50 mg/L per exchange (loading 250 mg) if aminoglycosides are contraindicated 5

Critical caveat: For mild β-lactam reactions (rash only), cephalosporins can often be used safely, particularly ceftazidime which has minimal cross-reactivity with penicillins.

Administration Details

Route and Technique:

• Intraperitoneal is mandatory—systemic IV antibiotics achieve inadequate peritoneal concentrations 1
• Add antibiotics to EACH dialysis exchange bag
• Use continuous dosing (antibiotics in every exchange) rather than intermittent for more consistent levels
• Dwell time should be at least 6 hours for the loading dose exchange

Antifungal Prophylaxis:

• Add oral nystatin 500,000 units four times daily or fluconazole 200 mg every 48 hours during antibiotic therapy to prevent secondary fungal peritonitis 1

Therapy Adjustment Algorithm

At 48-72 hours after culture results:

1. Gram-positive cocci (Staph/Strep):

   • Continue vancomycin, STOP Gram-negative coverage
   • If methicillin-susceptible S. aureus: switch to cefazolin 125 mg/L per exchange (more cost-effective)

2. Gram-negative organisms:

   • Continue appropriate agent based on sensitivities
   • STOP vancomycin
   • For ESBL-producing organisms: switch to meropenem 500 mg loading, then 125 mg/L per exchange 6

3. Culture-negative peritonitis:

   • Continue both agents for 14 days if clinical improvement
   • If no improvement by day 5: remove catheter

4. Fungal peritonitis:

   • Immediate catheter removal plus systemic antifungals (fluconazole 200 mg daily or echinocandin) 1

Duration of Therapy

• Standard: 14 days for most organisms
• S. aureus: 21 days minimum
• Pseudomonas/fungal: Catheter removal required; 14 days after removal
• Persistent symptoms >5 days: Consider catheter removal regardless of organism 1

Common Pitfalls to Avoid

1. Never use IV antibiotics alone—peritoneal concentrations will be inadequate even with systemic bacteremia
2. Don't delay empiric therapy waiting for culture results—start immediately after obtaining dialysate sample
3. Avoid aminoglycoside monotherapy for Gram-negative coverage—resistance rates are increasing
4. Don't continue empiric dual coverage beyond 72 hours if cultures identify a single organism
5. Never attempt catheter salvage with fungal peritonitis—removal is mandatory 1

The evidence strongly supports this approach, with the most recent pediatric 7 and adult 1 guidelines converging on these recommendations. The vancomycin-ceftazidime combination avoids aminoglycoside toxicity while maintaining excellent coverage 3, and newer pharmacokinetic data supports optimizing vancomycin dosing to 50 mg/L per exchange for adequate intraperitoneal levels 2.